Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseStem CellsMyeloablative AgonistsHematopoietic Stem CellsBusulfanGraft SurvivalTreatment OutcomeBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellDoxorubicinPlatelet CountPOEMS SyndromeTransplantation, IsogeneicBlood Cell CountPrednisoneCarboplatinLeukemia, Myeloid, AcuteImmunosuppressive AgentsLeukemiaDexamethasoneVidarabineFollow-Up StudiesRecombinant ProteinsAntineoplastic AgentsBone Marrow PurgingEmbryonic Stem CellsBlood CellsLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAdult Stem CellsMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationImmunophenotypingLymphocyte DepletionAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesBlood Transfusion, AutologousT-LymphocytesHLA AntigensLiver TransplantationBlood DonorsBone MarrowFlow CytometryLeukocytes, MononuclearCell SeparationPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-Lymphoma